Cyclin 3a Inhibitors are a class of compounds that inhibit the expression or activity of the cyclin 3a protein. Cyclin 3a is a protein that plays a critical role in the regulation of the cell cycle. Cyclin 3a binds to and activates cyclin-dependent kinase 2 (CDK2), which in turn phosphorylates and activates other proteins that are involved in cell cycle progression.
Cyclin 3a Inhibitors exert their effect by modulating different aspects of cyclin 3a biology. Some Cyclin 3a Inhibitors, such as small molecule inhibitors, can directly bind to cyclin 3a and prevent it from interacting with CDK2 or from being activated. Other Cyclin 3a Inhibitors, such as gene silencing agents (e.g., siRNA, shRNA), can reduce the expression of cyclin 3a mRNA or protein. By modulating cyclin 3a expression or activity, Cyclin 3a Inhibitors can influence cell cycle progression and cell growth. These compounds could potentially be used to study the role of cyclin 3a in various diseases and conditions, such as cancer and neurodegenerative disorders.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lipopolysaccharide, E. coli O55:B5 | 93572-42-0 | sc-221855 sc-221855A sc-221855B sc-221855C | 10 mg 25 mg 100 mg 500 mg | $98.00 $171.00 $425.00 $1560.00 | 12 | |
A glucocorticoid that activates the glucocorticoid receptor, leading to increased cyclin 3a expression. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
A vitamin A derivative that activates the retinoic acid receptor, leading to increased cyclin 3a expression. | ||||||